OVERVIEW
The market size of the anatomic pathology track and trace solutions is calculated to reach USD 743.2 million by 2024 at a CAGR of 9.93% during the forecast period. The rising volume of diagnostic tests conducted in anatomic pathology laboratories and the increasing number of legal cases involving cancer misdiagnosis are key drivers of market growth.
TABLE OF CONTENT
1 Global Anatomic Pathology Track and Trace Solutions MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Anatomic Pathology Track and Trace Solutions Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Anatomic Pathology Track and Trace Solutions Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Anatomic Pathology Track and Trace Solutions Market – Industry Market Entry
Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Anatomic Pathology Track and Trace Solutions Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Anatomic Pathology Track and Trace Solutions Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Anatomic Pathology Track and Trace Solutions Market – By Product (Market Size – &million/billion)
8.1 Software
8.2 Hardware
8.3 Consumables
9 Global Anatomic Pathology Track and Trace Solutions Market – By Technology
9.1 Barcode
9.2 RFID
10 Global Anatomic Pathology Track and Trace Solutions Market – By Application
10.1 Slides Tracking
10.2 Tissue Cassettes & Blocks Tracking
10.3 Specimen Tracking
11 Global Anatomic Pathology Track and Trace Solutions Market – By End-User
11.1 Hospital Laboratories
11.2 Independent and Reference Laboratories
11.3 Other
12 Global Anatomic Pathology Track and Trace Solutions Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Anatomic Pathology Track and Trace Solutions Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Anatomic Pathology Track and Trace Solutions Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Thermo Fisher Scientific Inc.
14.3 Leica Biosystems Nussloch GmbH (Subsidiary of Danaher Corporation)
14.4 General Data Healthcare Inc.
14.5 Ventana Medical Systems, Inc.
14.6 Zebra Technologies Corporation
14.7 Primera Technology, Inc.
14.8 Agilent Technologies, Inc.
14.9 Sunquest Information Systems, Inc.
14.10 Cerebrum Corp
14.11 AP Easy Software Solutions
14.12 Company 11 & more
15 Global Anatomic Pathology Track and Trace Solutions Market – Appendix
15.1 Sources
15.2 Abbreviations